Alzheimer's disease (AD) is a heterogeneous disorder that spans a continuum with multiple
phases, including preclinical, mild cognitive impairment, and dementia. Unlike for most other …

A continuous rise in life expectancy has led to an increase in the number of senior citizens,
now amounting to a fifth of the global population, and to a dramatic increase in the …

Introduction Polypharmacy is a growing problem in the United States. The use of multiple
medications increases the likelihood that a patient will experience potential drug interactions …

Background: Alzheimer's disease (AD) patients show heterogeneous cognitive profiles
which suggest the existence of cognitive subgroups. A deeper comprehension of this …

Introduction Underrepresented groups experience health disparities and a history of
exploitation by researchers and the health-care system that may contribute to distrust of new …

Independent life of the individuals suffering from Alzheimer's disease (AD) is compromised
due to their memory loss. As a result, they depend on others to help them lead their daily life …

背景认知功能是影响人们日常生活功能和生活质量的重要因素, 人在衰老过程中,
会出现认知功能下降, 发生轻度认知障碍(MCI), 甚至痴呆. 通过合理化老年综合评估(CGA) …

This chapter delves into the transformative role of Artificial Intelligence (AI) in understanding,
detecting, and treating neurodegenerative diseases, a subject of great relevance given the …

The dominant narrative around dementia argues that progression cannot be halted or
reversed. However, evidence on multimodal non-pharmacological treatments formulated …

Alzheimer disease (AD) is a chronic neurodegenerative condition that affects an individual's
cognitive function over an extended period. Treatment and prevention for AD have long …